Showing results (581-590 of 734) with videos related to
Sort By:
Pageof 74
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2021
Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell LymphomaMadiha Iqbal, Yennifer Gil Castano, Jonas Paludo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2012
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilizationIvana N M Micallef, Shirshendu Sinha, Dennis A Gastineau, et al.Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.Cancer Immunology, Immunotherapy : CII|July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosisBridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.Blood Cancer Journal|May 3, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohortsSanjal H Desai, Levi Pederson, Betsy LaPlant, et al.Angewandte Chemie (International Ed. in English)|July 12, 2012
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivoMuthusamy Jayaraman, Steven M Ansell, Barbara L Mui, et al.The Lancet. Haematology|April 3, 2022
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trialRajat Bannerji, Jon E Arnason, Ranjana H Advani, et al.British Journal of Haematology|May 30, 2018
Human Pegivirus infection and lymphoma risk and prognosis: a North American studyAngelo Fama, Jinhua Xiang, Brian K Link, et al.Blood Cancer Journal|March 27, 2021
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failureJennifer J Gile, Camden L Lopez, Gordon J Ruan, et al.Hematological Oncology|August 28, 2021
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg typeRobert M Kraft, Stephen M Ansell, Jose C Villasboas, et al.Pageof 74